News

Spectrum Pharmaceuticals and Allergan have announced that the FDA has granted Fast Track Designation (FTD) for the investigation of apaziquone (EOquin. It is developed for the treatment of

Oramed Pharmaceuticals has reported positive results from a phase 2A study of oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The study evaluated safety, tolerability and food

R-Tech Ueno has completed phase 1 clinical study of RK-023, a therapeutic drug of androgenetic alopecia. The phase 1 clinical study of RK-023 was a patch test, single

Medicago and Genopole have signed a partnership agreement with a plan to build a commercial facility to manufacture pandemic and seasonal influenza vaccines in France. Both the firms

Avidas and LaRon have entered into an agreement, where LaRon will co-promote Avidas’ Avidoxy defence kit and Scalacort defence kit . The Avidoxy defence kit includes Avidoxy, indicated

Actelion has posted its financial results for the first half of 2009. The company posts total net revenues of CHF855.2 million, an increase of 27% for the first

The Society of Chemical Manufacturers and Affiliates (SOCMA) has submitted comments for a hearing of the House Ways and Means Committee. The topic for hearing was on the

OSI and AVEO have expanded the drug discovery and translational research collaboration announced in October 2007. The alliance is anchored around developing molecular targeted therapies to target the

Sucampo and Takeda have reported top-line results from two identically-designed phase 3 clinical trials of lubiprostone (24 mcg, twice daily). The drug is for the management of opioid-induced